Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Disposition
Reported value range
Not reported

Riley Antony A Chief Financial Officer

Transaction date Aug 27, 2026
Public filing date Aug 27, 2026
Filing lag Filed same day

FBRX daily price context

Close on/before transaction
$76.99 Aug 27, 2026
First close after public filing
-- Unavailable
30-day return after filing
-- Through Unavailable

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Stock Option (right to buy) on Common Stock
Quantity / price
421 shares
SEC ownership
Direct
Transaction code
D
Form
4
Filing identifier
0001339375-26-000011
Filing cohort

Transactions in this filing

Showing 12 of 12
Trades
12
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Forte Biosciences, Inc. FBRX Other Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Current Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported
Forte Biosciences, Inc. FBRX Disposition Aug 27, 2026 Not reported